Search Results - "Shah, Ami"

Rheumatic and Musculoskeletal Immune‐Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature by Cappelli, Laura C., Gutierrez, Anna Kristina, Bingham, Clifton O., Shah, Ami A.

“…Objective Immune checkpoint inhibitors (ICIs) are improving prognoses in advanced stage cancers, but they also lead to immune‐related adverse events (IRAEs)…”
Get full text

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma by Moinzadeh, Pia, Fonseca, Carmen, Hellmich, Martin, Shah, Ami A, Chighizola, Cecilia, Denton, Christopher P, Ong, Voon H

“…We assessed the profile and frequency of malignancy subtypes in a large single-centre UK cohort for patients with scleroderma (systemic sclerosis; SSc). We…”
Get full text

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role? by Shah, Ami N., Gradishar, William J.

“…Anthracyclines have been a mainstay of breast cancer therapy for decades, with strong evidence demonstrating their impact on breast cancer survival. However,…”
Get full text

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab by Cappelli, Laura C, Gutierrez, Anna Kristina, Baer, Alan N, Albayda, Jemima, Manno, Rebecca L, Haque, Uzma, Lipson, Evan J, Bleich, Karen B, Shah, Ami A, Naidoo, Jarushka, Brahmer, Julie R, Le, Dung, Bingham, 3rd, Clifton O

“…Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have…”
Get more information

Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology by Cappelli, Laura C., MD, MHS, Shah, Ami A., MD, MHS, Bingham, Clifton O., MD

“…Immune checkpoint inhibitors (ICIs) are increasingly studied and used as therapy for a growing number of malignancies. ICIs work by blocking inhibitory…”
Get full text

Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation by Braaten, Tawnie J, Brahmer, Julie R, Forde, Patrick M, Le, Dung, Lipson, Evan J, Naidoo, Jarushka, Schollenberger, Megan, Zheng, Lei, Bingham, Clifton O, Shah, Ami A, Cappelli, Laura C

“…We sought to investigate the long-term outcomes of patients who develop immune checkpoint inhibitor (ICI)-induced inflammatory arthritis (IA), to define…”
Get more information

The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned From Hospitalized Heart Failure Registries by AMBROSY, Andrew P, FONAROW, Gregg C, GHEORGHIADE, Mihai, BUTLER, Javed, CHIONCEL, Ovidiu, GREENE, Stephen J, VADUGANATHAN, Muthiah, NODARI, Savina, LAM, Carolyn S. P, SATO, Naoki, SHAH, Ami N

“…Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both…”
Get full text

Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer by Chiec, Lauren, Shah, Ami N.

“…Advancements in the care for patients with early stage HER2-positive breast cancer is a story of incremental successes aimed at optimizing efficacy and…”
Get full text

Review: Cancer‐Induced Autoimmunity in the Rheumatic Diseases by Shah, Ami A., Casciola‐Rosen, Livia, Rosen, Antony

Get full text

The relationships between cancer and autoimmune rheumatic diseases by Cappelli, Laura C., Shah, Ami A.

“…Links between autoimmune rheumatic diseases and cancer continue to be elucidated. In this review, we explore this complex, bidirectional relationship. First,…”
Get full text

Letter to the Editor: Alternative Stomal Closure Technique by Gulack, Brian C., Shah, Ami N.

Get full text

Association between anti-SSSCA1 antibodies and cancer in systemic sclerosis by Wallwork, Rachel S, Shah, Ami A, Casciola-Rosen, Livia

“…Abstract Objective To define the clinical phenotype of SSc patients with antibodies against Sjogren’s syndrome (SS)/scleroderma autoantigen 1 (SSSCA1), and to…”
Get full text

Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis by Cappelli, Laura C, Dorak, Mehmet T, Bettinotti, Maria P, Bingham, Clifton O, Shah, Ami A

“…Abstract Objective To evaluate the frequency of HLA class I and II alleles associated with traditional forms of inflammatory arthritis in patients with immune…”
Get full text

Clot waveform analysis of prolonged activated partial thromboplastin time in various disorders by Kadu, Apeksha, Shah, Ami M, Goswami, Hansa

“…The prolongation in APTT reflects various disorders affecting the blood coagulation system. Automated coagulation analyzers such as ACL TOP, help in evaluating…”
Get full text

Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma by Shah, Ami A., Laiho, Marikki, Rosen, Antony, Casciola‐Rosen, Livia

“…Objective While compelling data suggest a cancer‐induced autoimmunity model in scleroderma patients with anti–RNA polymerase III large subunit (anti‐RPC155)…”
Get full text

Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen by Cappelli, Laura C., Brahmer, Julie R., Forde, Patrick M., Le, Dung T., Lipson, Evan J., Naidoo, Jarushka, Zheng, Lei, Bingham, Clifton O., Shah, Ami A.

“…Immune checkpoint inhibitors (ICIs) are a class of cancer immunotherapy, increasingly utilized to treat malignancies. Inflammatory arthritis (IA) is a…”
Get full text

Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome by Hall, John C., Baer, Alan N., Shah, Ami A., Criswell, Lindsey A., Shiboski, Caroline H., Rosen, Antony, Casciola‐Rosen, Livia

“…Objective Sjögren's syndrome (SS) is an autoimmune disease that targets the salivary and lacrimal glands. While all patients demonstrate inflammatory…”
Get full text

National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014 by Nguyen, Duc B, Shugart, Alicia, Lines, Christi, Shah, Ami B, Edwards, Jonathan, Pollock, Daniel, Sievert, Dawn, Patel, Priti R

“…Persons receiving outpatient hemodialysis are at risk for bloodstream and vascular access infections. The Centers for Disease Control and Prevention conducts…”
Get full text

Targeting Epidermal Growth Factor Receptor in Triple Negative Breast Cancer: New Discoveries and Practical Insights for Drug Development by Costa, Ricardo, Shah, Ami N, Santa-Maria, Cesar A, Cruz, Marcelo R, Mahalingam, Devalingam, Carneiro, Benedito A, Kwang Chae, Young, Cristofanilli, Massimo, Gradishar, William J, Giles, Francis J

“…Highlights • EGFR is commonly expressed in triple negative breast cancer. • Monoclonal antibodies targeting EGFR failed to show significant activity. •…”
Get full text

Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy by Jain, Sarika, Shah, Ami N., Santa-Maria, Cesar A., Siziopikou, Kalliopi, Rademaker, Alfred, Helenowski, Irene, Cristofanilli, Massimo, Gradishar, William J.

“…Purpose Activation of the phosphoinositide 3-kinase (PI3K) pathway is an important resistance mechanism to anti-HER2 therapies. This study aimed to assess the…”
Get full text